News Alert from Dow Jones Online News via Quote.com
Headline:
Ligand Pharmaceuticals' 3rd-Quarter Loss More Than Quadrupled
==================================================
Ligand Pharmaceuticals Inc. - San Diego, Calif.
3rd Quar Sept 30:
1998 1997
Revenue $3,947,000 $10,172,000
Inc bef item a (16,275,000) (11,564,000)
Extrd item b (30,000,000) ....
Net income a (46,275,000) (11,564,000)
Avg shrs 40,333,000 32,800,000
Shr earns (basic, diluted)
Net income a (1.15) (.35)
Figures in parentheses are losses.
a. Includes $2 million from realized gain on investments.
b. Covers the write-off of in-process technology.
Ligand Pharmaceuticals Inc. (LGND) develops small-molecule
drugs usedto regulate hormone-activated intracellular receptors.
Copyright (c) 1998 Dow Jones & Company, Inc.
All Rights Reserved.
|
